Please Wait...

ClearSite RBM

Detect Your Risks. Take the Right Action.

Managing risk and ensuring patient safety during a clinical trial are shared goals for researchers. Whether you are transitioning to a risk-based approach or are experienced with risk-based monitoring (RBM), Bioclinica's ClearSiteTM helps you:

Gain a holistic view of your RBM plan and:

  • Enhance patient safety
  • Improve data quality
  • Mitigate risk
  • Optimize resource allocation and utilization
  • Comply with the revised International Council on Harmonization guidelines (ICH E6(R2), Section 5)

See how our solutions help you develop strategies to leverage your data for continual success and to provide actionable insights for improved RBM.
Contact Us

 

Ask the Experts, Get Answers to your RBM Questions

ClearSite Professional Support Services

If you are new to RBM or need help developing a plan, Bioclinica's experts offer support on various levels. Our ClearSite professional support services team uses best practices to help you achieve the highest level of organizational efficiency and regulatory compliance, while doing so in a cost-efficient manner. 

Choose the level of assistance you need.

 

 

Implement Predictive Technology, Make Better Decisions

ClearSite Monitoring Technology

The ClearSite solution was built to not only facilitate traditional RBM activities — including centralized statistical monitoring — but also to support you in the fundamentals of overseeing site quality and patient safety. Unlike other solutions, the ClearSite technology system adapts to your processes as your experience and comfort with RBM grows.

Our system is the only system that aggregates qualitative and quantitative data to assess clinical and operational risk so you can make more informed decisions and act on potential issues before they happen.

Get started with ClearSite Monitoring Technology

 

Unleash Actionable Insights

Built on a Strong Foundation of Data

Aggregate: ClearSite technology integrates data from multiple sources — both qualitative and quantitative.

Assess: Then, our technology applies the software’s predictive analytics algorithm to identify the areas of greatest risk.

Act: Finally, we create a unique risk profile you can use to set initial target performance and monitoring recommendations for you protocol, site or a complete portfolio of studies.

Contact us for more information about ClearSite Solutions

ADDITIONAL RESOURCES

RBM Professional Services Offerings

Download Overview Sheet

What Effect Does ICH E6 R2 Have on Risk-Based Monitoring and Overall Quality Risk Management?

Download White Paper

Running Better Trials Taking an Intelligent Monitoring Approach

Download White Paper

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Our Medical Imaging team is in the spotlight for a job well done! https://t.co/fkmt0zvPhf https://t.co/D7YMTeiSd3
bioclinica (Yesterday)
RT @melfass: "What this agreement means is that we can allocate scarce resources to areas of higher risk" @US_FDA on MRA with @EMA_News at…
bioclinica (2 days ago)
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
bioclinica (4 days ago)
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
bioclinica (4 days ago)
Kristen Mauri shows the @DIA audience the value of risk based monitoring https://t.co/ssJCfc9gQ5
bioclinica (4 days ago)
Innovation Theater Kristin Mauri of @bioclinica presenting on RBM & TQM @DrugInfoAssn #DIA2017 https://t.co/zsGroQcpiU
bioclinica (4 days ago)

Latest Blogs: